TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32665691

Group type: EXPERIMENTAL
Intervention: Genomic information and correlated trait
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group records with size 24
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random assignment of animals to pens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bivariate model including correlated traits recorded individually
Number of subjects: 0
Study: 32641081

Group type: EXPERIMENTAL
Intervention: Preoperative immunonutrition (400 mL/day with arginine and ω‐3 fatty acids for 7 days)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Normal diet alone (control arm)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Preoperative immunonutrition
Number of subjects: 176
Study: 34942330

Group type: EXPERIMENTAL
Intervention: Multivitamin/Mineral Supplement (MVM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MVM plus Choline
Number of subjects: 0

Group type: COMPARATOR
Intervention: No study‐provided supplements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal levels of DMG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal levels of betaine in Trimester 3
Number of subjects: 0
Study: 33478494

Group type: EXPERIMENTAL
Intervention: Immediate postpartum levonorgestrel IUD placement
Number of subjects: 32

Group type: COMPARATOR
Intervention: Delayed postpartum levonorgestrel IUD placement
Number of subjects: 32
Study: 34674779

Group type: EXPERIMENTAL
Intervention: 10 mobile meditation sessions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 35066720

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting persistent positive margins after margin re-excision
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Clinical and pathologic variables used in the nomogram
Number of subjects: 289
Study: 32964140

Group type: EXPERIMENTAL
Intervention: Interactive app linked to primary care EHRs
Number of subjects: 934

Group type: COMPARATOR
Intervention: Usual health care (Control)
Number of subjects: 934
Study: 32536286

Group type: EXPERIMENTAL
Intervention: Novel femoral artery compression device (NFACD)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Manual compression (MC)
Number of subjects: 617
Study: 32769533

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Virtual Reality and Technique Guide (VR + TG)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Technique Guide (TG)
Number of subjects: 25
Study: 36493842

Group type: EXPERIMENTAL
Intervention: Tailored best practice advisory embedded within the electronic health record
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Usual care arm
Number of subjects: 1012
Study: 34229859

Group type: EXPERIMENTAL
Intervention: Morphine (0.02 mg.kg‐1.h‐1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fentanyl (0.3 mcg.kg‐1.h‐1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both Morphine and Fentanyl
Number of subjects: 100
Study: 32343918

Group type: EXPERIMENTAL
Intervention: Subcutaneous lidocaine infusion (SCLI) at a dosage of 10 mg/kg over 5.5 hours
Number of subjects: 2

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 2
Study: 33447371

Group type: EXPERIMENTAL
Intervention: Wolbachia mosquitoes releases
Number of subjects: 1100000

Group type: COMPARATOR
Intervention: Control areas (untreated)
Number of subjects: 1100000
Study: 35210767

Group type: EXPERIMENTAL
Intervention: Oral antibiotics prescribed in the prior 12 months
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: Obesity (compared to normal body mass index)
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 649
Study: 33558350

Group type: EXPERIMENTAL
Intervention: Nutri-Score
Number of subjects: 336

Group type: COMPARATOR
Intervention: References intakes (RIs)
Number of subjects: 336

Group type: COMPARATOR
Intervention: No label
Number of subjects: 336
Study: 32795381

Group type: EXPERIMENTAL
Intervention: Health TAPESTRY intervention (individualized plan of care from an interprofessional care team)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 33867880

Group type: EXPERIMENTAL
Intervention: Patients presenting with symptoms of <1 week
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Referrals from outside ophthalmologist
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Referrals from outside hospital
Number of subjects: 500

Group type: COMPARATOR
Intervention: Nonemergent visits
Number of subjects: 500
Study: 32431283

Group type: EXPERIMENTAL
Intervention: Global Health Wizard Hepatitis B Best Practice Alert (BPA)
Number of subjects: 4500
Study: 35889796

Group type: EXPERIMENTAL
Intervention: NO3−-rich concentrated beetroot juice (NIT; 12.8 mmol)
Number of subjects: 12

Group type: COMPARATOR
Intervention: NO3−-depleted concentrated beetroot juice (PLA; 0.04 mmol)
Number of subjects: 12
Study: 33399136

Group type: EXPERIMENTAL
Intervention: Hairstylists with CTS symptoms (73 out of 165, 42.2% prevalence); majority (73%) being females.
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Individual factors associated with CTS symptoms: being female (OR 9.99, 95% CI: 3.64-27.44), increasing age (OR 9.84, 95% CI: 2.74-35.36), length of employment (OR 3.73, 95% CI: 1.39-9.95), hair washing (OR 2.88, 95% CI: 1.41-5.85), awkward posture (OR 2.52, 95% CI: 1.03-6.19), great muscular effort (OR 2.39, 95% CI: 1.01-5.72).
Number of subjects: 165
Study: 35871473

Group type: EXPERIMENTAL
Intervention: Topical 4% sucralfate cream four times a day for 2 months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Peristomal wound care alone (Control)
Number of subjects: 44
Study: 34508901

Group type: EXPERIMENTAL
Intervention: Atomoxetine (40 mg)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 34882608

Group type: EXPERIMENTAL
Intervention: Novel combination of omega‐3 and omega‐6 fatty acids (1200 mg eicosapentaenoic acid, 300 mg docosahexaenoic acid, 150 mg γ‐linoleic acid)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (coconut and olive oil)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Novel combination of omega‐3 and omega‐6 fatty acids
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32188326

Group type: EXPERIMENTAL
Intervention: CPX-351
Number of subjects: 304

Group type: COMPARATOR
Intervention: 7+3
Number of subjects: 304
Study: 35041248

Group type: EXPERIMENTAL
Intervention: Bacopa monnieri (CDRI 08®)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 32779011

Group type: EXPERIMENTAL
Intervention: Oral moisturizing jelly (OMJ)
Number of subjects: 56

Group type: COMPARATOR
Intervention: GC dry mouth gel (GC)
Number of subjects: 56
Study: 33666009

Group type: EXPERIMENTAL
Intervention: Cannulated screw internal fixation
Number of subjects: 1068

Group type: COMPARATOR
Intervention: Bone plate internal fixation
Number of subjects: 1068
Study: 32969104

Group type: EXPERIMENTAL
Intervention: Adapted physical activity (APA) program, 8 sessions of 1.5 hours each
Number of subjects: 41
Study: 36459398

Group type: EXPERIMENTAL
Intervention: Volunteer-led, one-on-one, home-based digital literacy program
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (older adults awaiting participation in the program)
Number of subjects: 138
Study: 33865472

Group type: EXPERIMENTAL
Intervention: Smoke-free-home intervention plus indoor-air-quality feedback
Number of subjects: 1801

Group type: EXPERIMENTAL
Intervention: Smoke-free-home intervention only
Number of subjects: 1801

Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 1801
Study: 33561016

Group type: EXPERIMENTAL
Intervention: Pfs230D1-EPA/Alhydrogel
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pfs25-EPA
Number of subjects: 10
Study: 32444040

Group type: EXPERIMENTAL
Intervention: Aq+ (3056 mg day-1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Glu (2000 mg day-1)
Number of subjects: 30
Study: 35039174

Group type: EXPERIMENTAL
Intervention: IMPROVE programme (multifaceted implementation including educational activities, audit and feedback, reminders, organisational, team-directed, and patient-mediated activities)
Number of subjects: 1934

Group type: EXPERIMENTAL
Intervention: IMPROVE programme
Number of subjects: 1934
Study: 34868084

Group type: EXPERIMENTAL
Intervention: Leronlimab (weekly 700 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leronlimab (weekly treatment)
Number of subjects: 0
Study: 32901330

Group type: EXPERIMENTAL
Intervention: Fruquintinib (5 mg once daily for 3 weeks, followed by 1 week off in 28-day cycles)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo plus best supportive care
Number of subjects: 363
Study: 35343430

Group type: EXPERIMENTAL
Intervention: New sodium valproate formulation (epilenil 500‐mg coated tablet)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Depakene formulation
Number of subjects: 0
Study: 34737416

Group type: EXPERIMENTAL
Intervention: Umbilical Cord Blood Sampling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Admission Blood Sampling
Number of subjects: 0
Study: 33172957

Group type: EXPERIMENTAL
Intervention: Overweight or obese patients who lost weight (≥5%)
Number of subjects: 1869

Group type: EXPERIMENTAL
Intervention: Underweight or normal weight women who lost weight (≥5%)
Number of subjects: 1869

Group type: EXPERIMENTAL
Intervention: Overweight or obese patients
Number of subjects: 1869

Group type: EXPERIMENTAL
Intervention: Overall population of 1869 women
Number of subjects: 1869
Study: 34384419

Group type: EXPERIMENTAL
Intervention: Primary Arthrodesis (PA)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Open Reduction and Internal Fixation (ORIF)
Number of subjects: 112
Study: 33118638

Group type: EXPERIMENTAL
Intervention: Integrative Cognitive‐Affective Therapy for BED
Number of subjects: 112

Group type: COMPARATOR
Intervention: Cognitive‐behavioral therapy delivered using guided self‐help
Number of subjects: 112
Study: 34427006

Group type: EXPERIMENTAL
Intervention: Al-Anon Intensive Referral (AIR)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 279
Study: 34180157

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36159262

Group type: EXPERIMENTAL
Intervention: Margetuximab plus chemotherapy
Number of subjects: 2
Study: 33619171

Group type: EXPERIMENTAL
Intervention: m276-SL-PBD (0.5 mg/kg on days 1, 8, and 15)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: m276-SL-PBD (single 0.5 mg/kg dose)
Number of subjects: 26

Group type: COMPARATOR
Intervention: m276-SL-PBD
Number of subjects: 26
Study: 32203234

Group type: EXPERIMENTAL
Intervention: Baby-led approach (BLISS)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Traditional spoon-feeding (Control)
Number of subjects: 206
Study: 33637429

Group type: EXPERIMENTAL
Intervention: Deliberate cognitive processing intervention (developing contingency plans)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (no specific instructions)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78
Study: 33238982

Group type: EXPERIMENTAL
Intervention: LIM nomogram developed from logistic regression analysis
Number of subjects: 3797

Group type: EXPERIMENTAL
Intervention: LIM nomogram
Number of subjects: 3797
Study: 35863366

Group type: EXPERIMENTAL
Intervention: Moderate-intensity statin with ezetimibe combination therapy (rosuvastatin 10 mg with ezetimibe 10 mg)
Number of subjects: 3780

Group type: COMPARATOR
Intervention: High-intensity statin monotherapy (rosuvastatin 20 mg)
Number of subjects: 3780

Group type: EXPERIMENTAL
Intervention: Moderate-intensity statin with ezetimibe combination therapy
Number of subjects: 3780

Group type: COMPARATOR
Intervention: High-intensity statin monotherapy
Number of subjects: 3780
Study: 34705999

Group type: EXPERIMENTAL
Intervention: Photobiomodulation with a laser wavelength of 660 nm
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Photobiomodulation with a laser wavelength of 808 nm
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no light treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Placebo group (equipment switched off)
Number of subjects: 60
Study: 32388895

Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control (no metastasectomy)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Pulmonary metastasectomy vs Control
Number of subjects: 93
Study: 35780241

Group type: EXPERIMENTAL
Intervention: Weekly educational one-way text messages on sexo-reproductive health
Number of subjects: 398
Study: 32658515

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral prevention (CBP) program
Number of subjects: 298

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 298
Study: 34635005

Group type: EXPERIMENTAL
Intervention: ICT tool (ARATA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 78
Study: 34301734

Group type: EXPERIMENTAL
Intervention: Patient-initiated unlimited access to outpatient visits
Number of subjects: 357

Group type: COMPARATOR
Intervention: Usual care through regular prescheduled visits
Number of subjects: 357
Study: 32427354

Group type: EXPERIMENTAL
Intervention: Intraduodenal infusion of voriconazole (VRZ) at 7.5 mg/h from 8 to 16 hours and 15 mg/h from 16 to 24 hours combined with midazolam (MDZ) at 0.26 mg/h for 24 hours
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of voriconazole (VRZ) at 7.5 mg/h from 8 to 16 hours and 15 mg/h from 16 to 24 hours combined with midazolam (MDZ) at 0.26 mg/h for 24 hours
Number of subjects: 6
Study: 36454199

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control condition (no VR)
Number of subjects: 44
Study: 33308274

Group type: EXPERIMENTAL
Intervention: Capsaicin application (depth and dose not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control treatment groups)
Number of subjects: 0
Study: 35938323

Group type: EXPERIMENTAL
Intervention: Tongdu Xingshen acupuncture and moxibustion combined with cognitive training
Number of subjects: 84

Group type: COMPARATOR
Intervention: Cognitive training (control group)
Number of subjects: 84
Study: 32719982

Group type: EXPERIMENTAL
Intervention: Volume-stable cross-linked collagen matrix (VCMX)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Non-cross-linked collagen matrix (XCM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 12
Study: 34775069

Group type: EXPERIMENTAL
Intervention: PVI+6L group
Number of subjects: 390

Group type: COMPARATOR
Intervention: PVI group
Number of subjects: 390
Study: 34853062

Group type: EXPERIMENTAL
Intervention: Atrasentan
Number of subjects: 3668

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3668
Study: 32183911

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Aged 20-39 years
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Aged 40-59 years
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Respondents who had lost their jobs
Number of subjects: 551
Study: 35503345

Group type: EXPERIMENTAL
Intervention: Blood pressure self-monitoring with telemonitoring
Number of subjects: 850

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Self-monitoring group
Number of subjects: 850
Study: 33516143

Group type: EXPERIMENTAL
Intervention: KXS 3.2 g/day
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 36362743

Group type: EXPERIMENTAL
Intervention: Cervical extension traction (SG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Neck stretching and exercises + infrared radiation (SG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neck stretching and exercises + infrared radiation (CG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dermatomal somatosensory evoked potentials (DSSEPS) (both groups)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cervical lordosis (CL) correlation (both groups)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: DSSEPs correlation (SG)
Number of subjects: 30
Study: 32967646

Group type: EXPERIMENTAL
Intervention: Client-Centered Representative Payee (CCRP)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: CCRP
Number of subjects: 160
Study: 35910937

Group type: EXPERIMENTAL
Intervention: Mindfulness yoga for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (no mindfulness yoga)
Number of subjects: 0
Study: 35092962

Group type: EXPERIMENTAL
Intervention: Fetal endoscopic tracheal occlusion (FETO)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (antenatal expectant management)
Number of subjects: 41
Study: 32882101

Group type: EXPERIMENTAL
Intervention: Renal denervation
Number of subjects: 50
Study: 37946220

Group type: EXPERIMENTAL
Intervention: Probiotics plus atomoxetine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Atomoxetine only
Number of subjects: 80
Study: 32479187

Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 234
Study: 35179044

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 52
Study: 34321595

Group type: EXPERIMENTAL
Intervention: Self‐directed learning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participatory learning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Closed‐Circuit Television (CCTV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CCTV‐plus (with feedback)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall intervention (all phases combined)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: After-WHO moments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Before-WHO moments
Number of subjects: 0
Study: 33352920

Group type: EXPERIMENTAL
Intervention: Vitamin D (3200 IU D3/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 30
Study: 35022282

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily plus FOLFIRI regimen (5-fluorouracil, leucovorin, irinotecan)
Number of subjects: 54

Group type: COMPARATOR
Intervention: FOLFIRI regimen (5-fluorouracil, leucovorin, irinotecan)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Celecoxib plus FOLFIRI regimen
Number of subjects: 54
Study: 34029129

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 1
Study: 34069117

Group type: EXPERIMENTAL
Intervention: HC diet with 1% sodium butyrate (HCSB)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: HC diet with 1% sodium β‐hydroxybutyrate (HCHB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: HC diet
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low-concentrate (LC) diet
Number of subjects: 80
Study: 32173886

Group type: EXPERIMENTAL
Intervention: Transcranial photobiomodulation (tPBM) with 1,064-nm laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study: 34339697

Group type: EXPERIMENTAL
Intervention: Maternal glyphosate exposure
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Maternal AMPA exposure
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Binary analysis of glyphosate and AMPA
Number of subjects: 163
Study: 33159620

Group type: EXPERIMENTAL
Intervention: Whole-body vibration at 18 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole-body vibration at 6 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole-body vibration at 12 Hz
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study: 33227833

Group type: EXPERIMENTAL
Intervention: FM‐UD+HBO2
Number of subjects: 20

Group type: COMPARATOR
Intervention: FM‐UD
Number of subjects: 20
Study: 35832019

Group type: EXPERIMENTAL
Intervention: Villages et Écoles Assainis (VEA) programme
Number of subjects: 332

Group type: COMPARATOR
Intervention: Control
Number of subjects: 332
Study: 34899124

Group type: EXPERIMENTAL
Intervention: Behavioural therapy (biofeedback training)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Interferential current training
Number of subjects: 50
Study: 35589610

Group type: EXPERIMENTAL
Intervention: Ladarixin (LDX) 400 mg twice-daily for three cycles of 14 days on/14 days off
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Ladarixin (LDX)
Number of subjects: 76
Study: 33130034

Group type: EXPERIMENTAL
Intervention: High-Intensity Circuit Training (HICT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (HICT performed twice at baseline and end)
Number of subjects: 33
Study: 35725754

Group type: EXPERIMENTAL
Intervention: Machine learning model based on peritumoral radiomics features
Number of subjects: 339

Group type: COMPARATOR
Intervention: Conventional model based on tumor consolidation/tumor (C/T) ratio
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Radiomics model for STAS prediction
Number of subjects: 339

Group type: COMPARATOR
Intervention: Lobectomy patients
Number of subjects: 339
Study: 34378672

Group type: EXPERIMENTAL
Intervention: Group 1 (painful TMJ clicking)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group 2 (painless TMJ clicking)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group 3 (control group)
Number of subjects: 90
Study: 35372636

Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Sensorial saturation
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control
Number of subjects: 180
Study: 32065861

Group type: EXPERIMENTAL
Intervention: Aquablation therapy
Number of subjects: 181

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 181
Study: 35575732

Group type: EXPERIMENTAL
Intervention: It Gets Better project (IGBP) videos (n=242)
Number of subjects: 483

Group type: COMPARATOR
Intervention: Control video (n=241)
Number of subjects: 483
Study: 32200225

Group type: EXPERIMENTAL
Intervention: Treatment targeting reductions in negative affect or increases in positive affect (15 sessions)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Cortisol reactivity (measured as peak during stress task minus basal level)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Cortisol reactivity
Number of subjects: 35